Status:
TERMINATED
Diabetes and Smoking Cessation: a Gender-Oriented Study
Lead Sponsor:
Carole Clair
Conditions:
Smoking Cessation
Diabetes Type 2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
People with diabetes still smoke at equivalent rates as non-diabetics. There is lack of evidence regarding interventions for smoking cessation among individuals with diabetes. The aim of this project ...
Detailed Description
Smoking and diabetes are both major public health burden. They act synergistically on morbidity and mortality. Micro and macro-vascular complications are dramatically increased among diabetic smokers;...
Eligibility Criteria
Inclusion
- Informed Consent as documented by signature;
- Having smoked \> 100 cigarettes during his/her entire life and currently smoking cigarettes (no minimal threshold);
- Having been diagnosed with a type 2 diabetes;
- Being ≥ 18 years old;
- Speaking and understanding French
Exclusion
- Not being able to give an informed consent and follow the procedure of the study (due to dementia, psychological disorder, language problem);
- Being pregnant or breastfeeding;
- Being enrolled in another smoking cessation study or program or in a multi-behavioral program including smoking cessation;
- Enrolment of the investigator or other research collaborators, their family members, employees and other dependent persons;
- Planning to move out of Switzerland within the next year.
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 10 2021
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT03426423
Start Date
March 1 2018
End Date
March 10 2021
Last Update
August 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Primary Care and Public Health
Lausanne, Canton of Vaud, Switzerland, 1010